Genex Pharmaceutical (GENX) Financial Statements
Genex Pharmaceutical Financial Overview
Genex Pharmaceutical's market cap is currently $3.57K. The company's EPS TTM is ―; its P/E ratio is 0.01; Genex Pharmaceutical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 07 | Dec 06 | Dec 05 | Dec 04 | Sep 03 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 2.87M | $ 2.22M | $ 2.19M | $ 2.07M | $ -301.00 |
| Operating Income | $ 662.13K | $ 667.57K | $ 920.59K | $ 992.12K | $ -52.26K |
| EBITDA | $ 718.27K | $ 722.37K | $ 980.43K | $ 1.05M | $ -48.87K |
| Net Income | $ 342.55K | $ 618.96K | $ 625.01K | $ 1.01M | $ -52.26K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 8.65M | $ 5.74M | $ 4.42M | $ 2.94M | $ 22.07K |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -430.12K | $ -192.20K | $ -296.19K | $ -326.00K | $ -10.24K |
| Total Liabilities | $ 3.91M | $ 1.68M | $ 1.11M | $ 326.49K | $ 9.01K |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ 528.40K | $ 1.18M | $ 1.38M | $ 83.94K | $ -44.74K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD